Purchase Order 36C24526P0274
Award Date 3/2/26
Potential Completion Date 3/4/26
Potential Value $38K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Brooks, KY 40109, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a firm fixed-price purchase order to Theracom, L.L.C. for TAKHZYRO 150MG/ML injection in 2ML syringe formulation on February 24, 2026. The contract has a ceiling value of $38,875.02 with an ultimate completion date of March 24, 2026. The award was made without a set-aside designation, reflecting full and open competition. Theracom, a Kentucky-based pharmaceutical specialty distributor headquartered in...
- Theracom, L.L.C., a child entity, has been awarded a firm fixed price purchase order by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs, for the supply of TAKHZYRO 150MG. The contract, issued on December 1, 2025, carries a ceiling value of $75,478.12 and is scheduled for ultimate completion by December 30, 2025. The contract was awarded without a set-aside designation and will be performed in Brooks, Kentucky. TAKHZYRO...
- Theracom, L.L.C., a child entity, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 2 on October 20, 2025, for the supply of TAKHZYRO (pegtanercept) 150MG/ML injection in a 2ML syringe formulation. This is a pharmaceutical supply contract with a ceiling value of approximately $37.7K, with an ultimate completion date of November 20, 2025. The contract was awarded without a set-aside designation, and the place of performance is listed as Brooks, Kentucky. This...
- This is a firm fixed-price delivery order awarded to Takeda Pharmaceuticals America Inc. by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). The contract is for the delivery of TAKHZYRO 150 MG, a specialized pharmaceutical product, with a ceiling value of $36,984.28 and a period of performance through August 5, 2025. The contract is not set aside and is awarded under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule...
- Takeda Pharmaceuticals America Inc. was awarded a $36,984.28 firm fixed-price delivery order for TAKHZYRO 150 MG, a specialized pharmaceutical treatment for hereditary angioedema. The contract, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, is a child order under Takeda's broader Blanket Purchase Agreement with the VA National Acquisition Center valued at $131.04 million. The award was issued without a set-aside designation, reflecting the specialized and...
- <p>This is a firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 22, a civilian agency within the U.S. Department of Veterans Affairs, to Theracom, L.L.C. for the provision of VPRIV medication required to treat patients with Gaucher's disease. The contract has a ceiling value of $279,109.31 and a period of performance ending on June 20, 2017. The contract was awarded on October 1, 2015 and does not include a set-aside designation.</p>
- The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $36,101.68 firm fixed price delivery order against the company's GSA Schedule contract for Pharmaceuticals and Drugs. The delivery order is for TAKHZYRO 150MG/ML SYRINGE 2ML SYRINGE (2) to be supplied to Veterans Integrated Service Network 9, with performance taking place in Lexington, Massachusetts from September 6-7, 2023. As the prime contractor, Takeda Pharmaceuticals America...
- This federal contract award is for the pharmaceutical product TAKHZYRO 150 MG, which was awarded to Takeda Pharmaceuticals America Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The contract, valued at $36,984.28, is a delivery order with a firm fixed-price pricing type, and the ultimate completion date is August 27, 2025. The contract was awarded by the Veterans Integrated Service Network 5, a civilian defense agency, and is part of the General...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $17,351.60 to United Therapeutics Corp for the supply of Tyvaso 64 microgram kits. The contract, issued under the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), is structured as a firm fixed-price delivery order with no set-aside designation. The ultimate completion date is March 11, 2026, with the order placed on...
- The Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5) awarded a $28,975.20 delivery order to Travere Therapeutics, Inc. for the supply of Thiola 100 mg, a specialized pharmaceutical used to treat cystinuria and related kidney disorders. This award, issued on November 5, 2025, with an ultimate completion date of November 7, 2025, represents a firm fixed-price delivery order issued under Travere's existing Federal Supply Schedule contract for Pharmaceuticals and...